4//SEC Filing
Anderson Karen M. 4
Accession 0001847903-24-000182
CIK 0001847903other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:09 PM ET
Size
14.7 KB
Accession
0001847903-24-000182
Insider Transaction Report
Form 4
Anderson Karen M.
Chief People Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2024-12-13$3.85/sh+5,876$22,623→ 77,401 total - Exercise/Conversion
Share Option (right to buy)
2024-12-17−10,624→ 43,510 totalExercise: $3.85Exp: 2033-02-01→ Ordinary Shares (10,624 underlying) - Sale
Ordinary Shares
2024-12-13$17.01/sh−5,876$99,974→ 71,525 total - Exercise/Conversion
Share Option (right to buy)
2024-12-13−5,876→ 54,134 totalExercise: $3.85Exp: 2033-02-01→ Ordinary Shares (5,876 underlying) - Exercise/Conversion
Ordinary Shares
2024-12-17$3.85/sh+10,624$40,902→ 82,149 total - Sale
Ordinary Shares
2024-12-17$17.32/sh−10,624$184,036→ 71,525 total
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2024.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.99 to $17.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.99 to $17.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001762176
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:09 PM ET
- Size
- 14.7 KB